COMPASS Pathways’ key patents upheld by the US Patent and Trademark Office Post published:June 6, 2023 Post category:Press Release
Algernon Pharmaceuticals to Present Phase 2 Ifenprodil Cough Data at the 2023 American Cough Conference Post published:June 6, 2023 Post category:Press Release
Cedar Clinical Research, by Numinus, the top enrolling clinical research site for MindMed’s Phase 2B study evaluating MM-120 Post published:June 5, 2023 Post category:Press Release
Algernon NeuroScience Announces Successful Completion of Highest Planned Single Dose in DMT Phase 1 Trial; Accelerates Plans for Phase 2 Stroke and TBI Studies Post published:June 5, 2023 Post category:Press Release
Terran Biosciences announces exclusive licensing deal with Pierre Fabre for idazoxan; Terran completes key development milestones Post published:June 2, 2023 Post category:Press Release
Silo Pharma Announces Participation on Webull Corporate Communications Service Platform Post published:June 2, 2023 Post category:Press Release
Numinus to Participate in a Water Tower Research Fireside Chat on Wednesday, June 7, 2023 Post published:June 2, 2023 Post category:Press Release
atai Life Sciences to Participate in Upcoming June Investor Conferences Post published:June 1, 2023 Post category:Press Release
Reunion Neuroscience Announces US$13.1 Million Take-Private Transaction with MPM BioImpact Post published:June 1, 2023 Post category:Press Release
State of Kentucky Sets aside $42 Million for Psychedelic Research, with Focus on Ibogaine Post published:May 31, 2023 Post category:News